Transient aplastic crisis triggered by parvovirus B19 in a family with hereditary spherocytosis

by Nicolas Cilla, Léa Domitien, Neila Arrada, Delphine Chiffre, Perrine Mahe, Laure Vincent, Patricia Aguilar-Martinez, Vincent Foulongne
Published 2020-01-01

Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells

by Claire Gourzones, Céline Bellanger, Sylvain Lamure, Ouissem Karmous Gadacha, Elvira Garcia De Paco, Laure Vincent, Guillaume Cartron, Bernard Klein, Jérôme Moreaux
Published 2019-03-01

PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs

by Laurie Herviou, Alboukadel Kassambara, Stéphanie Boireau, Nicolas Robert, Guilhem Requirand, Carsten Müller-Tidow, Laure Vincent, Anja Seckinger, Hartmut Goldschmidt, Guillaume Cartron, Dirk Hose, Giacomo Cavalli, Jerome Moreaux
Published 2018-10-01

A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment

by Sylvain Lamure, Franciane Paul, Anne-Laure Gagez, Jérémy Delage, Laure Vincent, Nathalie Fegueux, Anne Sirvent, Eve Gehlkopf, Jean Luc Veyrune, Lu Zhao Yang, Tarik Kanouni, Valère Cacheux, Jérôme Moreaux, Beatrice Bonafoux, Guillaume Cartron, John De Vos, Patrice Ceballos
Published 2020-07-01

A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab

by Joseph Mikhael, Karim Belhadj-Merzoug, Cyrille Hulin, Laure Vincent, Philippe Moreau, Cristina Gasparetto, Ludek Pour, Ivan Spicka, Ravi Vij, Jeffrey Zonder, Djordje Atanackovic, Nashat Gabrail, Thomas G. Martin, Aurore Perrot, Samira Bensfia, Qilong Weng, Claire Brillac, Dorothée Semiond, Sandrine Macé, Kathryn P. Corzo, Xavier Leleu
Published 2021-05-01